METTL14 regulates the epidermal growth factor receptor (EGFR)/phosphoinositide 3-kinase (PI3K)/AKT signaling pathway to inhibit migration, invasion, and EMT of HCC cells (Shi et al., 2020c). Here, EGFR is linked to hepatocellular carcinoma.